Skip to main content
. 2022 Aug 9;127(8):1497–1506. doi: 10.1038/s41416-022-01941-0

Table 1.

Patient characteristics.

Characteristic N = 48
Age, median (range) 60 (27–74)
Gender
  Male 34 (70.8%)
  Female 14 (29.2%)
Race
  African–American 5 (10.4%)
  Caucasian 41 (85.4%)
  Other 2 (4.2%)
BMI, median [IQR] 25.4 (21.3–28.2)
Smoking history, pack years (PY)
  Never smoker 23 (47.9%)
  ≤10 PY 7 (14.6%)
  >10 PY 17 (35.4%)
  Unknown 1 (2.1%)
Primary site
  Anterior tongue 6 (12.5%)
  Retromolar trigone 2 (4.2%)
  Lip 1 (2.1%)
  Oropharynx, tonsil and base of the tongue 20 (41.7%)
  Hypopharynx 2 (4.2%)
  Aryepiglottic fold 1 (2.1%)
  Larynx 5 (10.4%)
  Nasal cavities 1 (2.1%)
  Nasopharynx 2 (4.2%)
  Parotid gland 3 (6.3%)
  Unknown primary 1 (2.1%)
  Other 4 (8.3%)
Disease state
  Recurrent 40 (80.3%)
  Primary 7 (14.6%)
  Metastatic 1 (2.1%)
p16 + (for oropharynx) 14 (29.2%)
ECOG PS
  1 26 (54.2%)
  0 20 (40.7%)
  Unknown 2 (4.2%)